Atossa Therapeutics, Inc.
ATOS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001488039
No open-market purchases or sales by Atossa Therapeutics, Inc. insiders were filed in the last 90 days; 31 institutions reported holding it in 13F filings for Q2 2026, worth $2.60M in total; no superinvestor holds it.
Q4 2023 vs. Q3 2023
How the institutions holding Atossa Therapeutics, Inc. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Q4 2023 | Change |
|---|---|---|---|
| Holders | 54 | 49 | −5 |
| Shares | 16.2M | 16.0M | −202.6K (−1.3%) |
| Value | $11.9M | $14.1M | +$2.19M (+18.4%) |
New holders (3)
Institutions that held Atossa Therapeutics, Inc. at the end of Q4 2023 but not at the end of Q3 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Bank of Montreal | 352,700 | $359.8K | 0.00% |
| Squarepoint Ops LLC | 63,065 | $55.5K | 0.00% |
| Regions Financial Corp | 30,000 | $26.4K | 0.00% |
Sold out (8)
Institutions that held Atossa Therapeutics, Inc. at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| Virtu Financial LLC | 80,728 | $59.0K |
| Two Sigma Securities, LLC | 36,466 | $26.9K |
| HRT Financial LP | 29,138 | $21.0K |
| HighTower Advisors, LLC | 20,100 | $15.0K |
| Jane Street Group, LLC | 17,302 | $12.7K |
| Victory Capital Management Inc | 13,823 | $10.2K |
| NBC Securities, Inc. | 150 | $0 |
| Cutler Group LP | 574 | $0 |